Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family
Tài liệu tham khảo
Ahern, 2010, Interleukin-23 drives intestinal inflammation through direct activity on T cells, Immunity, 33, 279, 10.1016/j.immuni.2010.08.010
Awasthi, 2007, A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells, Nat. Immunol., 8, 1380, 10.1038/ni1541
Awasthi, 2009, Th17 cells: from precursors to players in inflammation and infection, Int. Immunol., 21, 489, 10.1093/intimm/dxp021
Boulanger, 2003, Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex, Science, 300, 2101, 10.1126/science.1083901
Bryson, 2005, Protein structure prediction servers at University College London, Nucleic Acids Res., 33, W36, 10.1093/nar/gki410
Chaturvedi, 2011, Cutting edge: human regulatory T cells require IL-35 to mediate suppression and infectious tolerance, J. Immunol., 186, 6661, 10.4049/jimmunol.1100315
Collison, 2010, IL-35-mediated induction of a potent regulatory T cell population, Nat. Immunol., 11, 1093, 10.1038/ni.1952
Collison, 2012, The composition and signaling of the IL-35 receptor are unconventional, Nat. Immunol., 13, 290, 10.1038/ni.2227
Collison, 2008, Interleukin-35: odd one out or part of the family?, Immunol. Rev., 226, 248, 10.1111/j.1600-065X.2008.00704.x
Collison, 2007, The inhibitory cytokine IL-35 contributes to regulatory T-cell function, Nature, 450, 566, 10.1038/nature06306
Cua, 2003, Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain, Nature, 421, 744, 10.1038/nature01355
Diveu, 2009, IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells, J. Immunol., 182, 5748, 10.4049/jimmunol.0801162
Egilmez, 2010, Tumor-resident CD8+ T-cell: the critical catalyst in IL-12-mediated reversal of tumor immune suppression, Arch. Immunol. Ther. Exp. (Warsz), 58, 399, 10.1007/s00005-010-0097-7
Goujon, 2010, A new bioinformatics analysis tools framework at EMBL-EBI, Nucleic Acids Res., 38, W695, 10.1093/nar/gkq313
Halaby, 1999, The immunoglobulin fold family: sequence analysis and 3D structure comparisons, Protein Eng., 12, 563, 10.1093/protein/12.7.563
Hilton, 1996, Saturation mutagenesis of the WSXWS motif of the erythropoietin receptor, J. Biol. Chem., 271, 4699, 10.1074/jbc.271.9.4699
Huang, 2011, Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35, J. Immunol., 187, 462, 10.4049/jimmunol.1100259
Jones, 2011, Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily, Immunol. Res., 10.1007/s12026-011-8209-y
Larkin, 2007, Clustal W and Clustal X version 2.0, Bioinformatics, 23, 2947, 10.1093/bioinformatics/btm404
Li, 2010, A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery, Nat. Struct. Mol. Biol., 17, 105, 10.1038/nsmb.1719
Lupardus, 2008, The structure of interleukin-23 reveals the molecular basis of p40 subunit sharing with interleukin-12, J. Mol. Biol., 382, 931, 10.1016/j.jmb.2008.07.051
McGeachy, 2009, The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo, Nat. Immunol., 10, 314, 10.1038/ni.1698
Neufert, 2007, IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1, Eur. J. Immunol., 37, 1809, 10.1002/eji.200636896
Niedbala, 2007, IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells, Eur. J. Immunol., 37, 3021, 10.1002/eji.200737810
Oppmann, 2000, Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12, Immunity, 13, 715, 10.1016/S1074-7613(00)00070-4
Pflanz, 2002, IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells, Immunity, 16, 779, 10.1016/S1074-7613(02)00324-2
Rousseau, 2010, IL-27 structural analysis demonstrates similarities with ciliary neurotrophic factor (CNTF) and leads to the identification of antagonistic variants, Proc. Natl. Acad. Sci. U.S.A., 107, 19420, 10.1073/pnas.1005793107
Rousseau, 2008, Ciliary neurotrophic factor, cardiotrophin-like cytokine, and neuropoietin share a conserved binding site on the ciliary neurotrophic factor receptor alpha chain, J. Biol. Chem., 283, 30341, 10.1074/jbc.M803239200
Shimozato, 2009, The secreted form of p28 subunit of interleukin (IL)-27 inhibits biological functions of IL-27 and suppresses anti-allogeneic immune responses, Immunology, 128, e816, 10.1111/j.1365-2567.2009.03088.x
Stern, 1994, Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide, Nature, 368, 215, 10.1038/368215a0
Stern, 1994, Antigenic peptide binding by class I and class II histocompatibility proteins, Structure, 2, 245, 10.1016/S0969-2126(00)00026-5
Stumhofer, 2010, A role for IL-27p28 as an antagonist of gp130-mediated signaling, Nat. Immunol., 11, 1119, 10.1038/ni.1957
Trinchieri, 2003, Interleukin-12 and the regulation of innate resistance and adaptive immunity, Nat. Rev. Immunol., 3, 133, 10.1038/nri1001
Tripp, 1995, Secondary response to Listeria infection requires IFN-gamma but is partially independent of IL-12, J. Immunol., 155, 3427, 10.4049/jimmunol.155.7.3427
Uyttenhove, 2011, Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection, J. Leukoc. Biol., 89, 1001, 10.1189/jlb.1210699
Villarino, 2006, IL-27 limits IL-2 production during Th1 differentiation, J. Immunol., 176, 237, 10.4049/jimmunol.176.1.237
Wang, 2009, Structural biology of shared cytokine receptors, Annu. Rev. Immunol., 27, 29, 10.1146/annurev.immunol.24.021605.090616
Watford, 2003, The biology of IL-12: coordinating innate and adaptive immune responses, Cytokine Growth Factor Rev., 14, 361, 10.1016/S1359-6101(03)00043-1
Yoon, 2000, Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12, EMBO J., 19, 3530, 10.1093/emboj/19.14.3530
Zandian, 2011, Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2, Gene Ther., 18, 734, 10.1038/gt.2011.32
